Bolt Biotherapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BOLT and other ETFs, options, and stocks.

About BOLT

Bolt Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer. Its pipeline includes BDC-1001, a HER2-targeting Boltbody Immune-Stimulating Antibody Conjugate (ISAC), BDC-3042, a myeloid-modulating antibody, and multiple Boltbody ISAC collaboration programs. 

CEO
Randall C. Schatzman
CEORandall C. Schatzman
Employees
100
Employees100
Headquarters
Redwood City, California
HeadquartersRedwood City, California
Founded
2015
Founded2015
Employees
100
Employees100

BOLT Key Statistics

Market cap
41.94M
Market cap41.94M
Price-Earnings ratio
-0.60
Price-Earnings ratio-0.60
Dividend yield
—
Dividend yield—
Average volume
72.96K
Average volume72.96K
High today
$1.11
High today$1.11
Low today
$1.07
Low today$1.07
Open price
$1.10
Open price$1.10
Volume
23.29K
Volume23.29K
52 Week high
$2.03
52 Week high$2.03
52 Week low
$0.84
52 Week low$0.84

Analyst ratings

83%

of 6 ratings
Buy
83.3%
Hold
16.7%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.